Ignite Creation Date:
2024-05-06 @ 2:32 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04340362
Status:
COMPLETED
Last Update Posted:
2023-07-10
First Post:
2020-04-07
Brief Title:
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Glomerulosclerosis Focal Segmental |
Keywords: